Semperit Aktiengesellschaft Holding (SEIGY)
| Previous close | 5.52 |
| Open | 5.52 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 5.52 - 5.52 |
| 52-week range | 5.52 - 10.60 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 454.261M |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | 2.44 |
| EPS (TTM) | 2.26 |
| Earnings date | N/A |
| Forward dividend & yield | 0.40 (7.17%) |
| Ex-dividend date | 02 May 2022 |
| 1y target est | N/A |
- EQS Group
Semperit AG Holding delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected
EQS-News: Semperit AG Holding / Key word(s): Quarterly / Interim Statement/Quarter ResultsSemperit AG Holding delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected 18.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement. Semperit delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected Revenue at Grou
- EQS Group
Semperit AG Holding: Annual General Meeting approves dividend of EUR 1.50 per share for 2021
EQS-News: Semperit AG Holding / Key word(s): AGM/EGM/DividendSemperit AG Holding: Annual General Meeting approves dividend of EUR 1.50 per share for 2021 27.04.2022 / 15:28 The issuer is solely responsible for the content of this announcement.Vienna/Austria, 27 April, 2022 - At the 133rd Annual General Meeting of Semperit AG Holding, the Executive Board's proposal to pay a dividend of EUR 1.50 per share to shareholders for 2021 was approved.Herbert Ortner was re-elected as a member of the Superv
- EQS Group
Semperit AG Holding: Semperit posts record result again in 2021 despite difficult conditions - revenue exceed billion-euro threshold
EQS-News: Semperit AG Holding / Key word(s): Annual Results23.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Press releaseSemperit posts record result again in 2021 despite difficult conditions - revenue exceed billion-euro threshold- Consolidated sales increased by 27.4% to EUR 1,182.2 million in 2021- Revenue in the Industrial Sector grew by 16.2% to EUR 556.1 million and by 39.4% to EUR 626.1 million in the Medical Sector- EBITDA increased by 73.5% to EU
